- Home
- NCSM vs ANVS Comparison
NCSM vs ANVS Comparison
Compare NCSM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCSM | ANVS |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.9M | 111.3M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NCSM | ANVS |
|---|---|---|
| Price | $60.00 | $2.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 7.4K | ★ 314.1K |
| Earning Date | 06-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 239.22 | 62.92 |
| EPS | ★ 8.65 | N/A |
| Revenue | ★ $142,471,000.00 | N/A |
| Revenue This Year | $11.25 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | $5.58 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.20 | $1.11 |
| 52 Week High | $53.69 | $5.50 |
Technical Indicators
Market Signals| Indicator | NCSM | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 87.69 | 46.57 |
| Support Level | $35.60 | $2.27 |
| Resistance Level | N/A | $2.63 |
| Average True Range (ATR) | 2.37 | 0.19 |
| MACD | 2.16 | 0.03 |
| Stochastic Oscillator | 100.00 | 34.62 |
Price Performance
Historical ComparisonAbout NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.